# FDA Inspection 1158313 - Pfizer, Inc. - November 19, 2021

Source: https://www.keypedia.com/records/fda_inspections/pfizer-inc/c9642b42-7dca-45af-908a-ebb699daf5b4
Source feed: FDA_Inspections

> FDA Inspection 1158313 for Pfizer, Inc. on November 19, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1158313
- Company Name: Pfizer, Inc.
- Inspection Date: 2021-11-19
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1284680 - 2025-10-24](https://www.keypedia.com/records/fda_inspections/pfizer-inc/6ea9d015-a370-4c0e-bfa4-bbc8945b7daf)
- [FDA Inspection 1284680 - 2025-10-24](https://www.keypedia.com/records/fda_inspections/pfizer-inc/0bdd220c-7072-4bd4-b7b1-8e1427f8bd5f)
- [FDA Inspection 1256477 - 2024-12-13](https://www.keypedia.com/records/fda_inspections/pfizer-inc/d45be9cf-ef2e-4d2d-9638-08e91b31a22c)
- [FDA Inspection 1249289 - 2024-08-30](https://www.keypedia.com/records/fda_inspections/pfizer-inc/fca2fb99-8165-4115-906c-74a68359995f)
- [FDA Inspection 1230476 - 2024-07-19](https://www.keypedia.com/records/fda_inspections/pfizer-inc/4e4a347b-63ff-43b0-8128-9ba82dd7e8a2)

Company: https://www.keypedia.com/companies/pfizer-inc/4b87fbf2-bec7-4fde-adf0-4207cd7d93ff

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c